This inventor holds 2 USPTO granted patents. Top assignee: Salix Pharmaceuticals, Inc.. Active years: 1996-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996-1999
Title: Marvin H Sleisenger: Innovator in Colon Cancer Research
Introduction
Marvin H Sleisenger is a notable inventor based in Kentfield, CA (US). He has made significant contributions to the field of medicine, particularly in the area of colon cancer treatment. With a total of 2 patents, his work has the potential to impact the lives of many individuals affected by this disease.
Latest Patents
Sleisenger's latest patents focus on the use of 2-hydroxy-5-phenylazobenzoic acid derivatives as a method for colon cancer chemoprevention and chemotherapy. The present invention provides a method that involves administering a pharmaceutical composition containing an effective amount of these derivatives or their active metabolites to individuals suffering from or at risk of developing colon cancer.
Career Highlights
Throughout his career, Marvin H Sleisenger has been associated with Salix Pharmaceuticals, Inc., where he has worked on innovative solutions for gastrointestinal diseases. His dedication to research and development has positioned him as a key figure in the pharmaceutical industry.
Collaborations
Sleisenger has collaborated with various professionals in his field, including his coworker Lorin K Johnson. These partnerships have fostered an environment of innovation and have contributed to the advancement of medical treatments.
Conclusion
Marvin H Sleisenger's work in colon cancer research exemplifies the impact that dedicated inventors can have on healthcare. His innovative patents and collaborations continue to pave the way for new treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile